U.S. Pharma Ranking 2023

RealRate Inc.
2040 Martin Ave.
Santa Clara
California 95050
USA    www.realrate.ai
holger.bartel@realrate.ai
calendly.com/holger-bartel
+49 160 90 844     


 
Press Release

U.S. Pharma Ranking 2023

The new Pharma rating for 2023 has just been released by RealRate.

These are the top five Pharma companies in the U.S., measured by Economic Capital Ratio:

1.    THERAVANCE BIOPHARMA – 587%
2.    CHIMERIX INC. – 407%
3.    OCUPHIRE PHARMA INC. – 377%
4.    KINIKSA PHARMACEUTICALS LTD – 331%
5.    ZOMEDICA CORP. – 303%

The complete rating of 111 Pharma companies is published at https://realrate.ai/rankings/
446 companies achieved the ‘Top Rated’ award.

Founded in 2013 and based in the Cayman Islands, Theravance Biopharma is a biopharmaceutical company that discovers, develops, and commercializes respiratory medicines in the United States and Europe. Its current assets are $607 million.

Headquartered in Durham, North Carolina, and founded in 2000, Chimerix is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. It has total current assets of $279 million.

Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. It was founded in 2018 and is based in Farmington Hills, Michigan. It has current assets of $49 million.

Founded in 2015 and based in Bermuda, Austin, Texas, Kiniksa Pharmaceuticals develops medicines in the therapeutic areas of cardiovascular, dermatology, and autoimmune diseases. Its current assets are $460 million.

Headquartered in Ann Arbor, Michigan, and founded in 2013, Zomedica operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for pets. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. It has total current assets of $280 million.

CEO Dr. Holger Bartel: “The U.S. pharmaceutical industry is a powerhouse, generating billions in revenue annually. With a diverse landscape of companies, including giants like Pfizer, Merck, and Johnson & Johnson, it is a key player in global healthcare. In 2021, the industry's revenue exceeded $500 billion, illustrating its immense economic significance. In 2022, an especially profitable year for pharma, the eight biggest US pharmaceutical companies reported profits of $10 billion domestically on revenue of $214 billion.
Superior financial strength is critical in the Pharma industry, making sure products can get to market on time to help patients all over the world.”

About RealRate:
RealRate is an international rating agency based in Santa Clara and Berlin, founded in 2021. Using cutting-edge explainable Artificial Intelligence, we provide fair company ratings, avoiding any conflicts of interest. Combining AI and expert knowledge, financial strength is evaluated based on published annual reports. RealRate provides rankings for dozens of industries, like insurance, IT, real estate, food, and pharma. Only the best-rated companies are awarded the RealRate TOP Rated seal.

• Über RealRate GmbH
• Weitere Meldungen
• Diesen Pressetext kommentieren
• Pressemitteilung veraltet?